North Star Investment Management’s VanEck Biotech ETF BBH Stock Holding History

North Star Investment Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.5K	Hold	204	–	–	﹤0.01%	786
2026 Q1	$38.4K	Hold	204	–	–	﹤0.01%	796
2025 Q4	$38.7K	Hold	204	–	–	﹤0.01%	722
2025 Q3	$33.8K	Sell	204 -169	-45%	-$27.6K	﹤0.01%	734
2025 Q2	$57.2K	Hold	373	–	–	﹤0.01%	608
2025 Q1	$58.7K	Hold	373	–	–	﹤0.01%	588
2024 Q4	$58.6K	Hold	373	–	–	﹤0.01%	591
2024 Q3	$66.1K	Hold	373	–	–	﹤0.01%	559
2024 Q2	$62.8K	Hold	373	–	–	﹤0.01%	565
2024 Q1	$62K	Hold	373	–	–	﹤0.01%	580
2023 Q4	$61.6K	Sell	373 -42	-10%	-$6.46K	﹤0.01%	559
2023 Q3	$64.6K	Hold	415	–	–	0.01%	551
2023 Q2	$64.7K	Hold	415	–	–	0.01%	570
2023 Q1	$67.2K	Hold	415	–	–	0.01%	577
2022 Q4	$66.2K	Buy	415 +1	+0.2%	+$158	0.01%	554
2022 Q3	$58K	Hold	414	–	–	0.01%	514
2022 Q2	$60K	Hold	414	–	–	0.01%	520
2022 Q1	$67K	Hold	414	–	–	0.01%	527
2021 Q4	$78K	Hold	414	–	–	0.01%	523
2021 Q3	$84K	Hold	414	–	–	0.01%	500
2021 Q2	$84K	Hold	414	–	–	0.01%	503
2021 Q1	$73K	Hold	414	–	–	0.01%	492
2020 Q4	$70K	Hold	414	–	–	0.01%	481
2020 Q3	$67K	Hold	414	–	–	0.01%	464
2020 Q2	$68K	Hold	414	–	–	0.01%	444
2020 Q1	$53K	Sell	414 -45	-10%	-$6.06K	0.01%	473
2019 Q4	$64K	Sell	459 -231	-33%	-$30.4K	0.01%	511
2019 Q3	$81K	Buy	+690	New	+$85.8K	0.01%	460
2019 Q2	–	Sell	-690	Closed	-$89K	–	428
2019 Q1	$89K	Sell	690 -151	-18%	-$19.1K	0.01%	458
2018 Q4	$93K	Sell	841 -339	-29%	-$41K	0.01%	414
2018 Q3	$161K	Hold	1,180	–	–	0.02%	376
2018 Q2	$142K	Buy	1,180 +259	+28%	+$30.5K	0.02%	397
2018 Q1	$111K	Buy	921 +566	+159%	+$71K	0.01%	425
2017 Q4	$44K	Buy	355 +20	+6%	+$2.55K	0.01%	564
2017 Q3	$45K	Hold	335	–	–	0.01%	568
2017 Q2	$42K	Hold	335	–	–	0.01%	568
2017 Q1	$40K	Hold	335	–	–	0.01%	555
2016 Q4	$36K	Sell	335 -100	-23%	-$10.9K	0.01%	543
2016 Q3	$50K	Hold	435	–	–	0.01%	412
2016 Q2	$45K	Buy	+435	New	+$46.4K	0.01%	426

Other funds holding BBH

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

HFAS

Hummer Financial Advisory Services Chicago, Illinois $152M AUM 20.1% 1-Year Est. Return

VIP

Value Investment Professionals New York $119M AUM

North Star Investment Management's BBH Position: Q2 2026 in Review

North Star Investment Management held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 204 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

North Star Investment Management first reported a position in BBH in Q2 2016 and has held it in 40 quarters since. The position peaked at $161K in Q3 2018. 31 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

North Star Investment Management held 204 shares of VanEck Biotech ETF worth $41.5K as of Q2 2026.
North Star Investment Management left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #786 holding.
North Star Investment Management first reported a position in VanEck Biotech ETF in Q2 2016 and has held it in 40 quarters since.
North Star Investment Management's VanEck Biotech ETF position peaked at $161K in Q3 2018.
31 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.